NCT06219512

Brief Summary

Obesity and lack of exercise are one of the reasons for high blood pressure. Exercise can reduce the risk of cardiovascular events by reducing weight and blood pressure. The precise formulation of exercise prescription by cardiopulmonary exercise test (CPET) can effectively control hypertension. Our research group has formulated 50 "exercise prescriptions for hypertension population" in the early stage, but how to further effectively implement them needs to be discussed. Based on the previous experience of undertaking the project "Exercise Prescription for Hypertensive People" of General Administration of Sport of the People's Republic of China, this research group discussed the important role of intelligent information management in the clinical effect evaluation and effective implementation of exercise prescription for hypertension; To explore the feasibility of making exercise prescription for hypertension based on 6-min walking test, and whether it is not inferior to or equivalent to the accuracy and effectiveness of making exercise prescription by CPET. The relevant results will lay a foundation for exploring the broader adaptation of hypertension exercise prescription to the population.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
126

participants targeted

Target at P50-P75 for not_applicable hypertension

Timeline
7mo left

Started Feb 2024

Typical duration for not_applicable hypertension

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Feb 2024Dec 2026

First Submitted

Initial submission to the registry

February 22, 2023

Completed
11 months until next milestone

First Posted

Study publicly available on registry

January 23, 2024

Completed
9 days until next milestone

Study Start

First participant enrolled

February 1, 2024

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

January 23, 2024

Status Verified

January 1, 2024

Enrollment Period

2.9 years

First QC Date

February 22, 2023

Last Update Submit

January 12, 2024

Conditions

Keywords

hypertensionExercise prescriptionIntelligent information management6-min walking test (6MWT)Cardiopulmonary exercise test (CPET)

Outcome Measures

Primary Outcomes (7)

  • Systolic blood pressure, SBP

    systolic blood pressure (mmHg)

    through study completion, an average of 1 year

  • Diastolic blood pressure, DBP

    diastolic blood pressure (mmHg)

    through study completion, an average of 1 year

  • Heart rate, HR

    Heart rate (beats/min)

    through study completion, an average of 1 year

  • Pulse wave velocity, PWV

    pulse wave velocity

    through study completion, an average of 1 year

  • PWV

    pulse wave velocity

    through study completion, an average of 1 year

  • weight

    weight (kg)

    through study completion, an average of 1 year

  • Body mass index, BMI

    body mass index (kg/m\^2)

    through study completion, an average of 1 year

Secondary Outcomes (6)

  • Blood lipids

    through study completion, an average of 1 year

  • exercise hypertension

    through study completion, an average of 1 year

  • circadian rhythm of blood pressure

    through study completion, an average of 1 year

  • anxiety

    through study completion, an average of 1 year

  • depression

    through study completion, an average of 1 year

  • +1 more secondary outcomes

Study Arms (3)

CPET exercise prescription group

EXPERIMENTAL

Formulate exercise prescription of cardiopulmonary exercise test (CPET) according to the principle of FITT \[frequency, intensity, time and type\]

Behavioral: CPET exercise prescription

6MWT exercise prescription group

EXPERIMENTAL

Exercise prescription is set according to the recommendation of the Chinese expert consensus on the application of clinical norms of six-minute walking test

Behavioral: 6MWT exercise prescription

Regular exercise group

ACTIVE COMPARATOR

Carry out regular exercise as usual

Behavioral: Regular exercise

Interventions

Exercise mode: walk Frequency: 5 times/week

CPET exercise prescription group

Exercise mode: walk Frequency: 5 times/week

6MWT exercise prescription group

Regular exercise

Regular exercise group

Eligibility Criteria

Age45 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Overweight/obesity; Normal or normal high blood pressure after drug use; Grade 1 hypertension (whether taking medicine or not); Having sports habits; Sports risk is low and medium

You may not qualify if:

  • ≥ grade 2 Hypertension; High-risk hypertensive patients; Malignant hypertension, secondary hypertension, etc; Serious arrhythmia, heart failure, acute myocardial infarction; Severe stroke, liver and kidney insufficiency; Physical dysfunction and failure to cooperate for various reasons; Unable to conduct CPET; The Types and doses of antihypertensive drugs is still in the process of adjustment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Pelliccia A, Sharma S, Gati S, Back M, Borjesson M, Caselli S, Collet JP, Corrado D, Drezner JA, Halle M, Hansen D, Heidbuchel H, Myers J, Niebauer J, Papadakis M, Piepoli MF, Prescott E, Roos-Hesselink JW, Graham Stuart A, Taylor RS, Thompson PD, Tiberi M, Vanhees L, Wilhelm M; ESC Scientific Document Group. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021 Jan 1;42(1):17-96. doi: 10.1093/eurheartj/ehaa605. No abstract available.

    PMID: 32860412BACKGROUND

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Yang Xi, Doctor

    Peking University People's Hospital

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

February 22, 2023

First Posted

January 23, 2024

Study Start

February 1, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

January 23, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

To protect the privacy of patients in the maximum extent